logo
Nursing at Wrexham University Ranked Top in UK for Student Satisfaction

Nursing at Wrexham University Ranked Top in UK for Student Satisfaction

Nursing at Wrexham University has been ranked top in the UK for student satisfaction in the Complete University Guide 2026.
The Guide has also ranked the institution joint first in the UK – and first in Wales – for graduate prospects in the Nursing subject league table.
Wrexham University offers Nursing BN (Hons) courses in Adult Nursing, Children's Nursing and Mental Health Nursing at its Wrexham and St Asaph campuses.
Earlier this month, the university celebrated the news that it had been ranked top in Wales for student satisfaction overall in the Guide, as well as joint third in the UK for the same metric – out of 130 higher education institutions.
Professor Joe Yates, Vice-Chancellor, said:
'I am thrilled that nursing at Wrexham University has been ranked top in the UK for student satisfaction, as well as joint first in the UK for graduate prospects in the Nursing subject league table, in the Complete University Guide 2026.
'We are enormously proud of our strong reputation for student satisfaction, here at Wrexham – and these latest rankings demonstrate that our staff go above and beyond to support and empower our students in all that they do.
'This recognition speaks directly to the core of our 2030 Vision and Strategy, which is rooted in delivering an exceptional and inclusive student experience, as well as preparing our graduates to thrive in their chosen careers. In professions such as nursing, where compassionate, skilled professionals are in ever-increasing demand, we are proud to be leading the way nationally.
'Congratulations to our nursing colleagues, who work tirelessly to provide an excellent experience for our students.'
Some places are available on the University's Adult Nursing and Mental Health Nursing degree courses, which are starting in September.
You could be eligible for a fully funded NHS bursary to support your studies, find out more here .
Whether you've not quite decided where to study or even if university is right for you, come and see what we have to offer at our next open day, taking place on Friday, August 15, from 10am to 2pm.
Book your place here.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Labour MSP slams Scottish Government over autism support
Labour MSP slams Scottish Government over autism support

The Herald Scotland

time27 minutes ago

  • The Herald Scotland

Labour MSP slams Scottish Government over autism support

Mr Johnson, who has ADHD, said it feels as though the Scottish Government "want us to disappear" through their response to the report and what he described as a lack of urgency to act on problems highlighted. His comments come after Scotland's Autism organisations published a major survey report on Wednesday which found that some individuals are waiting over seven years for an autism diagnosis. It also found that half of respondents (50.65%) said it was hard or very hard to get a referral for an autism assessment, with just over a fifth (21%) saying they had been refused a referral at some point. Responding to the report, Mr Johnson said: 'This is a really chilling read. 'When people seek a diagnosis that is normally because of crisis, whether that is family crisis. For young people, school refusal. For adults, that could be relationships or work. 'So through these waits, you are prolonging that crisis. I am very concerned about all of this." READ MORE: Mr Johnson also said the focus on privatisation in the report was an important point. Just over a fifth (21%) of survey respondents had sought a private diagnosis, with long waiting times and the absence of a local adult assessment pathway cited as key factors. The average cost of a private diagnosis reported was £1,540 with the highest reported cost being £4,500. A total of 39% of those who had sought a private diagnosis reported that this had caused them financial hardship. Mr Johnson said: 'You are essentially saying that neurodevelopmental conditions are now not within the scope of the NHS and it is in essence privatising the provision of that healthcare for those people for whom it is an absolutely essential lifeline and that is unacceptable.' The Scottish Government has since said long waits for support are "unacceptable" and they are "working to improve access to the best possible care". In his response to the report, newly-appointed Wellbeing Minister Tom Arthur said accusations that the Scottish Government has 'removed' children from CAMHS waiting lists are false. However, Mr Johnson has since hit back saying that CAMHS specific waiting lists were not referred to in the report as being the place where children were 'removed' from and people have been removed from waiting lists for referral. "They have been removed. "CAMHS may not be the right service, but they haven't specified what is the right service," Mr Johnson told The Herald. "Right now it is impossible, either as a matter of policy or a matter of fact, to get an assessment for autism or ADHD as a child or adult. "Health boards have either stopped taking referrals or have such long waits they might as well have. 'It is Orwellian [from the Government]. To say it is false, just on a strict measurement, it is a fact." Last month, John Swinney told parliament that assessment referrals would not be accepted without a co-occurring mental health condition. Mr Johnson believes his own condition and autism have been neglected by the government. The MSP told The Herald: 'These conditions very often get described as invisible disabilities. "Right now it feels like the Scottish Government wants us to disappear because I don't see where we are in their plans at all." He added: 'Alternative pathways for a diagnosis of autism or ADHD have not been created. 'For new referrals like in big parts of Scotland such as Tayside there is not presently a route to an assessment or diagnosis on the NHS and there are other parts of Scotland where they are not accepting new referrals, such as in Lothian. 'In most of Scotland, the wait time is being measured in decades. I have got constituents who are already on waiting lists who have been told they will be for 17 years. 'That just means it is de facto not available.' The National Neurodevelopmental Specification for children and young people sets out the standards all children's services should follow to ensure those with neurodevelopmental support needs receive the support they need. The Scottish Government has said this makes clear that support should be put in place to meet the child or young person's requirements when they need it, rather than be dependent on a formal diagnosis. However, Mr Johnson argues this does not help those who are unsure about their condition. The Scottish Labour MSP said: 'The line recently that the government has been using about not needing a diagnosis to access help is again Orwellian. 'You need a diagnosis to know what help you need. You're actually asking people to guess and stumble upon what their condition is. 'It is also wrong.' The MSP said a broad range of local authority guidelines on additional help access often stipulates a diagnosis is required. The government's handling of ADHD is also a concern for Mr Johnson. A Holyrood committee has just launched an inquiry into treatment pathways and support for both ADHD and Autism Spectrum Disorder (ASD). 'For ADHD, medication is a key line of therapy," Mr Johnson said, "That's what the NICE guidelines state. You cannot get medication without a diagnosis and currently on the NHS that requires specialist, secondary care diagnosis from a psychiatrist. 'To say you don't need a diagnosis to access help is just factually incorrect. 'By not providing the therapy or assessment, you are going to cause those comorbid mental health conditions. Unassessed autism and ADHD is a massive cause of mental health problems. 'The Scottish Government are wishing away a problem and pretending they are not causing more issues and I worry about what this means for the mental health of our young people in Scotland.' The Labour MSP said the Scottish Government must recognise the 'crisis' in support and act urgently. 'They need to recognise the crisis. We need a pathway to assessment and diagnosis for those that need it. 'There's an urgency that's lacking here and that's just going to compound the crisis that so many people will be facing.' The 'Experiences of Autism Assessment and Diagnosis in Scotland' report was undertaken by Autism Rights Group Highland (ARGH), Autistic Mutual Aid Society Edinburgh (AMASE) and Scottish Ethnic Minority Autistics (SEMA) in partnership with Scottish Autism. These organisations are calling for a nationwide guarantee regarding timely access to assessments, an improved experience for people going through the process, and better provision of post-diagnostic support. They also want the government to introduce a national neurodevelopmental assessment guarantee, meaning any adult in Scotland can access an assessment pathway should they need to.

Woman told 'lumpy boobs' were normal but it was cancer
Woman told 'lumpy boobs' were normal but it was cancer

Daily Mirror

time2 hours ago

  • Daily Mirror

Woman told 'lumpy boobs' were normal but it was cancer

Lea Hughes was first reassured after spotting a small lump on her right breast aged 29 A woman was diagnosed with incurable stage 4 breast cancer after her tumour was dismissed as 'lumpy boobs' for two years. Lea Hughes, 38, first noticed a small lump on her right breast at the age of 29 but was reassured that her 'lumpy boobs' were merely hormonal. However, two years later, she noticed the lump had developed into a 'dimple'. On this occasion, doctors immediately referred her for a mammogram, ultrasound and biopsy. ‌ She was diagnosed with stage four breast cancer, which had spread to her liver and bones during the years it went undetected. Faced with an 'incurable' diagnosis, Lea pursued medications, therapies, and treatments to stabilise the disease and prevent further spread. ‌ But in August 2024, a scan revealed the cancer had reached her brain, and by March, it had also invaded her lungs. Lea, originally from the Wirral but now residing in Leytonstone, East London, has exhausted all NHS-funded treatment options and is now fundraising for private care. The former-fashion and retail marketer recalled: "When the doctor first told me I had lumpy boobs, I'd never heard of it before. But years on, I saw the lump had grown when I was putting a bikini on and I spotted a shadow caused by the lump. "Within weeks, I was diagnosed with stage four incurable cancer aged 31. Treatments contained it - until August 2024 - and now it's in my brain and lungs too. "I know the doctors and nurses so well now, after seven years at St. Bartholomew's Hospital, London. It's longer than any relationship I've ever had." Lea first spotted a small lump on the front of her right breast in 2015 and quickly sought medical advice. However, she was initially dismissed with the explanation that she simply had 'lumpy boobs' and at 29, without a family history, she wasn't eligible for further tests. ‌ Despite her attempts to get the issue addressed, it wasn't until a holiday in early 2018 that doctors took notice. She recalled noticing a shadow and a dimple while wearing a bikini, which led to an immediate referral to the hospital when she reported it over the phone. She underwent a series of examinations: "I went for a mammogram and an ultrasound, then a biopsy. When it came back as cancer, they did a breast MRI scan and noticed a shadow on my liver in the corner." ‌ Further investigations revealed the extent of her condition: "So they did full body scans - MRIs, PETs and bone scans - and learned it had spread to my liver and bones." Lea received a grim diagnosis of stage four incurable cancer in April 2018, coincidentally on Friday 13th. Treatment commenced at St. Bartholomew's Hospital, aiming to stabilise and contain the cancer. In June 2022, she underwent a single mastectomy. Unfortunately, one of the oral treatments proved too much for her body, resulting in hospitalisation in August 2023 due to severe side effects. She shared the harrowing experience: "I had hypercalcaemia - high calcium levels in the blood - and needed multiple blood transfusions. ‌ "It felt very real - I realised that this illness really could take me out." After opting for IV chemotherapy for 10 months, doctors successfully brought her cancer under control, allowing her to finish the treatment in May 2024. However, a routine scan in August 2024 revealed that her liver tumours had started to progress again, prompting a full-body scan to evaluate her eligibility for a new clinical trial. Unfortunately, this same scan uncovered that the cancer had also invaded her brain. Lea reflected on the discovery, sha ring: "It's one of those things, with stage four breast cancer, you know it can spread to the brain and you do worry. But I didn't expect it then, because I had no symptoms at all." ‌ Come September 2024, Lea began whole-brain radiotherapy before undertaking another series of IV chemotherapy treatments. Following this was radiotherapy targeting her spine, but by December 2024, her physical strength waned significantly as her body started to "give up". She recounted: "I'm 5ft 10ins and I went down to 7st. I was too weak to hold myself up - I was watching myself waste away. "I had to shave my head when I started losing my hair too. I didn't recognise myself and seeing those changes was very confronting." ‌ A brief period of improvement came in January 2025, but complications arose in March when she experienced serious breathing difficulties. The cancer had spread to her lungs, from which 4.5 litres of fluid were drained. Lea is now undergoing her sixth round of chemotherapy and has started fundraising efforts to access Enhertu, a targeted cancer therapy. Despite its availability on the NHS for certain types of breast cancer, Lea's extensive spread of the disease, including to her brain, leaves her ineligible for NHS-provided access to this particular drug. ‌ She holds onto hope that the drug, Enhertu, could be a game-changer for her brain cancer too as it's known to cross the blood-brain barrier – a rare trait not seen in many chemotherapy treatments. According to results gleaned from the DESTINY-Breast12 trial by creators AstraZeneca and Daiichi Sankyo, Enhertu revealed promising outcomes with a 61.6% one-year progression-free survival rate for patients who had both brain metastases and breast cancer. Yet, the steep cost of over £10,000 per cycle stands as a significant hurdle without NHS funding. Lea said: "I always try to lean into the positive - accepting how sh***y this is, but also not giving in. Yet the harshness of reality hits hard when treatments fail." Reflecting on her ordeal, she expressed disbelief: "I can't believe everything I've been through - you don't realise until you sit back and reflect. But I have no choice just to get on with it and keep fighting." Click to support her journey via fundraising here.

Woman dies from blood clot after taking common contraceptive used by millions
Woman dies from blood clot after taking common contraceptive used by millions

Daily Mirror

time3 hours ago

  • Daily Mirror

Woman dies from blood clot after taking common contraceptive used by millions

Chloe Alicia Ellis, 29, died three days after she was wrongly diagnosed and discharged from hospital. She had earlier been diagnosed as having a suspected pulmonary embolism in an online assessment after she collapsed at home A young woman tragically died three days after being misdiagnosed with a viral illness and subsequently discharged from hospital, said a coroner. Chloe Alicia Ellis, a 29 year old wildlife officer, had previously been identified as potentially having a pulmonary embolism during an online assessment, but this crucial information was not available to the medical staff when she visited Dewsbury and District Hospital. ‌ Chloe had complained of chest and back pain, as well as breathlessness. During an NHS 111 online assessment, she disclosed her history of using the Yasmin contraceptive pill to manage her endometriosis, an inquest in Wakefield was told. ‌ Following the assessment on 31 August last year, she was advised to visit A&E due to the algorithm's conclusion that she might have a pulmonary embolism. However, Chloe herself was not informed of this potential diagnosis. Regrettably, the results of the NHS online assessment were not accessible to the staff at Dewsbury Hospital. The inquest heard that an 'inadequate' history was taken from Chloe, as she was not questioned about her medication history or specifically her use of oral contraception. Inadequate history taking The hospital Trust has since implemented measures to address this issue of inadequate history taking, reports Yorkshire Live. Chloe, who was married, was diagnosed with a viral illness at Dewsbury Hospital and sent home. She collapsed at home on 3 September and, despite the best efforts of paramedics and clinicians at Leeds General Infirmary, she died later that day. The death of a young woman was caused by a pulmonary embolism, with the contributory factor being endometriosis treatment via the oral contraceptive pill. ‌ Coroner Oliver Longstaff has since acted, by contacting the West Yorkshire Integrated Care Board, issuing a stark warning to help prevent similar tragedies in the future. At the heart of the coroner's report is the revelation that Chloe's life might have been saved if Dewsbury hospital staff had been alerted to her history with the contraceptive pill. In his conclusion, the coroner made it clear: "...had a history of her oral contraceptive use been obtained when Chloe attended a local hospital Emergency Department on 31 August 2024, she would have been given anticoagulation medication and undergone tests that would have revealed the pulmonary embolism. ‌ "She would have received effective treatment for the pulmonary embolism and, on the balance of probabilities, would not have died three days later." Serious concerns During the inquest, Mr Longstaff voiced four serious concerns regarding the events leading up to Chloe's death. It was disclosed at the inquest that while it is technically feasible for NHS 111 online assessment outcomes to be shared with A&E staff, whether this happens is decided by the local Integrated Care Board. ‌ Furthermore, the panel learned that connectivity to NHS 111 online assessments had not been established for the Mid Yorkshire Teaching NHS Trust, which administers Dewsbury hospital, due to decisions made by the West Yorkshire Integrated Care Board. The coroner has highlighted that if the NHS online assessment completed by Chloe had been accessible to the medical staff at Dewsbury District Hospital, they would have been aware of her use of oral contraceptives and the suspected pulmonary embolism. The coroner remarked: "The availability of NHS 111 online assessments to clinicians in emergency departments may assist in the obtaining of a full history and may act as a failsafe against inadequate history taking in Emergency Departments." ‌ Mr Longstaff has requested a response from the West Yorkshire Integrated Care Board to his Prevention of Future Deaths report by August 8. Regret Expressing regret over the incident, the NHS West Yorkshire Integrated Care Board stated: "We are very sorry to hear about what happened to Chloe, and our sincere condolences go to her loved ones. "We have been reviewing the points raised by the Coroner and we are working with all our relevant partners to understand the learning and the current arrangements to establish what changes are required in order to prevent similar losses in future." ‌ In the wake of Chloe's heartbreaking passing, her friends, family, and colleagues have rallied behind a charity walk in her honour. The Dozy Wanderers walk aims to gather £5,000 by trekking 213 miles from Ingleborough to Scarborough, passing through a nature reserve in Hull known as Paull Holme Strays. Wildlife defender Yorkshire Wildlife Trust, where Chloe had been a fervent wildlife advocate, is among the charities set to benefit from her legacy. Chloe held a university degree and had experience as a planning officer for a local authority in West Yorkshire. ‌ A charity spokesperson expressed to Yorkshire Live how much of a dedicated wildlife champion Chloe was. "A keen defender and champion of wildlife, Chloe was a planning advocate at Yorkshire Wildlife Trust, responding to applications, including those that could have a detrimental impact on the Trust's nature reserves and Yorkshire's wildlife. "Her commitment to defending nature and her ability to navigate complex ecological and policy matters led to a number of successes for the Trust." ‌ Rachael Bice, CEO at Yorkshire Wildlife Trust, shared: "Chloe was a delight to work with and is dearly missed by us all. She was always enthusiastic in sharing her knowledge and experience to defend nature; a true natural advocate for wildlife. We will continue to honour Chloe's memory by upholding the values she championed and by striving to protect the natural world she loved so dearly." Chloe's passion The Trust praised Chloe's "passion for wildlife and dedication to our cause were truly inspiring, with her work being instrumental in securing a safe future for Yorkshire's wildlife." Yorkshire Wildlife Trust has expressed its heartfelt support for the Dozy Wanderers' fundraising initiative in memory of Chloe Ellis, a cherished colleague who tragically passed away last year at just 29 years old. In a social media post, the trust stated: "We at Yorkshire Wildlife Trust are deeply moved by the Dozy Wanderers' heartfelt initiative to raise funds in memory of our beloved colleague, Chloe Ellis, who tragically passed away last year at the age of 29." ‌ The trust highlighted Chloe's remarkable dedication to wildlife conservation, saying: "Chloe's passion for wildlife and dedication to our cause were truly inspiring, with her work being instrumental in securing a safe future for Yorkshire's wildlife." Ambitious trek The Dozy Wanderers' ambitious 203-mile trek from Ingleborough to Paull Holme Strays in Hull, concluding in Scarborough in July 2025, aims to raise £5,000 for Yorkshire Wildlife Trust and Dementia UK. The trust urged everyone to rally behind the cause, stating: "Let's honour Chloe's memory and support these amazing causes together." The Just Giving page has already garnered over £4,000 from 90 supporters, with the funds being split between Yorkshire Wildlife Trust and Dementia UK. ‌ The Just Giving page can be found here. Tributes have been pouring in on the page, with one donor writing: "For beautiful Chloe. Always in our hearts." Another supporter shared: "For beautiful Chloe. May you always smile down on us. Missed every day. Loved for always." A well-wisher added: "Good luck. Chloe was a lovely young lady."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store